Up a level |
Abdullahi, Sa'ad T, Soyinka, Julius O, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Bolarinwa, Rahman A, Olarewaju, Olusola J, Bakare-Odunola, Moji T, Winterberg, Markus, Tarning, Joel, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2020)
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by <i>CYP2B6</i> c.516G>T Genotypes.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64 (3).
e00947-e00919.
Abdullahi, Sa'ad T, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Soyinka, Julius O, Bolarinwa, Rahman A, Olarewaju, Olusola J, Bakare-Odunola, Moji T, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2019)
Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?
British journal of clinical pharmacology, 85 (3).
pp. 540-550.
Abdullahi, Sa'ad T, Soyinka, Julius O, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Bolarinwa, Rahman A, Olarewaju, Olusola J, Bakare-Odunola, Moji T, Winterberg, Markus, Tarning, Joel, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2020)
<i>CYP2B6</i>*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers.
JOURNAL OF CLINICAL PHARMACOLOGY, 60 (3).
pp. 351-360.